537 related articles for article (PubMed ID: 26572245)
1. Complementing the inflammasome.
Triantafilou M; Hughes TR; Morgan BP; Triantafilou K
Immunology; 2016 Feb; 147(2):152-64. PubMed ID: 26572245
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria-Endoplasmic Reticulum Contact Sites Mediate Innate Immune Responses.
Misawa T; Takahama M; Saitoh T
Adv Exp Med Biol; 2017; 997():187-197. PubMed ID: 28815531
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
Cui J; Chen Y; Wang HY; Wang RF
Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
[TBL] [Abstract][Full Text] [Related]
4. The inflammasome: a danger sensing complex triggering innate immunity.
Pétrilli V; Dostert C; Muruve DA; Tschopp J
Curr Opin Immunol; 2007 Dec; 19(6):615-22. PubMed ID: 17977705
[TBL] [Abstract][Full Text] [Related]
5. The complement system, toll-like receptors and inflammasomes in host defense: three musketeers' one target.
Kumar V
Int Rev Immunol; 2019; 38(4):131-156. PubMed ID: 31066339
[TBL] [Abstract][Full Text] [Related]
6. Innate immunity as a target for acute cardioprotection.
Zuurbier CJ; Abbate A; Cabrera-Fuentes HA; Cohen MV; Collino M; De Kleijn DPV; Downey JM; Pagliaro P; Preissner KT; Takahashi M; Davidson SM
Cardiovasc Res; 2019 Jun; 115(7):1131-1142. PubMed ID: 30576455
[TBL] [Abstract][Full Text] [Related]
7. Self, non-self, and danger: a complementary view.
Köhl J
Adv Exp Med Biol; 2006; 586():71-94. PubMed ID: 16893066
[TBL] [Abstract][Full Text] [Related]
8. Updated overview of molecular pathways involved in the most common monogenic autoinflammatory diseases.
Lucherini OM; Rigante D; Sota J; Fabiani C; Obici L; Cattalini M; Gattorno M; Cantarini L
Clin Exp Rheumatol; 2018; 36 Suppl 110(1):3-9. PubMed ID: 29742053
[TBL] [Abstract][Full Text] [Related]
9. Innate immunity networks during infection with Borrelia burgdorferi.
Oosting M; Buffen K; van der Meer JW; Netea MG; Joosten LA
Crit Rev Microbiol; 2016; 42(2):233-44. PubMed ID: 24963691
[TBL] [Abstract][Full Text] [Related]
10. β2-glycoprotein I and oxidative inflammation in early atherogenesis: a progression from innate to adaptive immunity?
Matsuura E; Lopez LR; Shoenfeld Y; Ames PR
Autoimmun Rev; 2012 Dec; 12(2):241-9. PubMed ID: 22569463
[TBL] [Abstract][Full Text] [Related]
11. Autophagy and inflammasome interplay.
Martins JD; Liberal J; Silva A; Ferreira I; Neves BM; Cruz MT
DNA Cell Biol; 2015 Apr; 34(4):274-81. PubMed ID: 25757059
[TBL] [Abstract][Full Text] [Related]
12. Innate Immune Receptors.
Muñoz-Wolf N; Lavelle EC
Methods Mol Biol; 2016; 1417():1-43. PubMed ID: 27221479
[TBL] [Abstract][Full Text] [Related]
13. Cross Kingdom Immunity: The Role of Immune Receptors and Downstream Signaling in Animal and Plant Cell Death.
Roudaire T; Héloir MC; Wendehenne D; Zadoroznyj A; Dubrez L; Poinssot B
Front Immunol; 2020; 11():612452. PubMed ID: 33763054
[TBL] [Abstract][Full Text] [Related]
14. Nucleotide-binding oligomerization domain-like receptors and inflammasomes in the pathogenesis of non-microbial inflammation and diseases.
Mason DR; Beck PL; Muruve DA
J Innate Immun; 2012; 4(1):16-30. PubMed ID: 22067846
[TBL] [Abstract][Full Text] [Related]
15. Activation of the Innate Immune Receptors: Guardians of the Micro Galaxy : Activation and Functions of the Innate Immune Receptors.
De Nardo D
Adv Exp Med Biol; 2017; 1024():1-35. PubMed ID: 28921463
[TBL] [Abstract][Full Text] [Related]
16. Advances in Nod-like receptors (NLR) biology.
Barbé F; Douglas T; Saleh M
Cytokine Growth Factor Rev; 2014 Dec; 25(6):681-97. PubMed ID: 25070125
[TBL] [Abstract][Full Text] [Related]
17. Innate and intrinsic antiviral immunity in skin.
Kawamura T; Ogawa Y; Aoki R; Shimada S
J Dermatol Sci; 2014 Sep; 75(3):159-66. PubMed ID: 24928148
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic potential of modifying inflammasomes and NOD-like receptors.
Di Virgilio F
Pharmacol Rev; 2013 Jul; 65(3):872-905. PubMed ID: 23592611
[TBL] [Abstract][Full Text] [Related]
19. The role of innate immunity receptors in the pathogenesis of inflammatory bowel disease.
Elia PP; Tolentino YF; Bernardazzi C; de Souza HS
Mediators Inflamm; 2015; 2015():936193. PubMed ID: 25821356
[TBL] [Abstract][Full Text] [Related]
20. Inflammasomes and rheumatic diseases: evolving concepts.
Sidiropoulos PI; Goulielmos G; Voloudakis GK; Petraki E; Boumpas DT
Ann Rheum Dis; 2008 Oct; 67(10):1382-9. PubMed ID: 17921182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
